Search Otava Chemical Collections On-Line
Otava Ltd., a leading provider of synthetic organic compounds for research and drug discovery, - offers a number of products including focused libraries, screening compounds libraries and chemical building blocks. Our combined databases comprise more than a million compounds.
One can do different searches in four categories:
Stock Screening Compounds
There are three different search options:
”Text Search” option allows finding substances by molecular formula or catalog number.This search option can also be used to find compounds with predicted biological properties in our “Target-Focused Libraries” category using names of target proteins or diseases.
“Structure search” option is useful for searching compounds by structure drawing. Exact Search and Substructure Search are possible.
“Advanced Search” option is a combination of the first two options. Additionally, there is a possibility to operate with physical and chemical parameters of compounds such as molecular weight, cLogP, H-bond donors/acceptors and rotatable bonds.
OTAVA Ltd. is an international science-based chemical company founded in 1997 with production laboratories and offices in Europe (Kiev, Ukraine) and North America (Toronto, Canada).
Our company carries a diverse set of products and services for pharmaceutical companies, universities, research institutes and government agencies. We specialize in the development and production of building blocks, screening compounds, fluorescent dyes and kinase-related products, including various inhibitors and kinase focused libraries.
Our facilities and highly-experienced personnel make possible a variety of contract research projects and custom syntheses of complex biologically active substances. Our Molecular Modelling Department provides the full range of advanced computational services.
P.O. Box 88
Kyiv 187, 03187
Phone/Fax : +380 44 522 24 58
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Search Otava Chemical Collections On-Line here
News-ID: 163526 • Views: 1551
More Releases from Otava Ltd.
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to